Volume 272, Number 24, Issue of June 13, 1997 pp. 15184-15188
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

Two Activation States of the Prohormone Convertase PC1 in the Secretory Pathway

(Received for publication, March 3, 1997, and in revised form, April 14, 1997)

Isabelle Jutras , Nabil G. Seidah ^§ , Timothy L. Reudelhuber and Véronique Brechler

From the  Laboratories of Molecular Biochemistry of Hypertension and ^§ Biochemical Neuroendocrinology, Clinical Research Institute of Montreal (IRCM), Montreal, Quebec, Canada H2W 1R7

PC1, a neuroendocrine member of the prohormone convertase family of serine proteinases, is implicated in the processing of proproteins in the secretory pathway. PC1 is synthesized as a zymogen and cleaves not only its own profragment in the endoplasmic reticulum, but a subset of protein substrates in the Golgi apparatus and in the Golgi-distal compartments of the regulated secretory pathway. Likewise, mouse PC1 (mPC1) has previously been shown to cleave human prorenin in GH4 cells (that contain secretory granules) while being unable to cleave prorenin in cells, such as Chinese hamster ovary (CHO) or BSC-40, which are devoid of secretory granules. In the current study, we show that removal of a C-terminal tail of mPC1 allows the efficient cleavage of prorenin in the constitutive secretory pathway of CHO cells. The C-terminal tail thus appears to act as an inhibitor of PC1 activity against certain substrates in the endoplasmic reticulum and Golgi apparatus, and its removal, which occurs naturally in secretory granules, may explain the observed granule-specific processing of certain proproteins. These results also demonstrate that PC1 is present in a partially active state prior to the secretory granules where it is processed to a maximally active state.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. J. Kang, I. Toma, A. Sipos, E. J. Meer, S. L. Vargas, and J. Peti-Peterdi The Collecting Duct Is the Major Source of Prorenin in Diabetes Hypertension, June 1, 2008; 51(6): 1597 - 1604. [Abstract] [Full Text] [PDF]

				L. E. Pritchard and A. White Neuropeptide Processing and Its Impact on Melanocortin Pathways Endocrinology, September 1, 2007; 148(9): 4201 - 4207. [Abstract] [Full Text] [PDF]

				H. G. Sutton-Walsh, S. Whelly, and G. A. Cornwall Differential Effects of GnRH and Androgens on Cres mRNA and Protein in Male Mouse Anterior Pituitary Gonadotropes J Androl, November 1, 2006; 27(6): 802 - 815. [Abstract] [Full Text] [PDF]

				D. J. Lloyd, S. Bohan, and N. Gekakis Obesity, hyperphagia and increased metabolic efficiency in Pc1 mutant mice Hum. Mol. Genet., June 1, 2006; 15(11): 1884 - 1893. [Abstract] [Full Text] [PDF]

				L. R. Mulcahy, C. A. Vaslet, and E. A. Nillni Prohormone-Convertase 1 Processing Enhances Post-Golgi Sorting of Prothyrotropin-releasing Hormone-derived Peptides J. Biol. Chem., December 2, 2005; 280(48): 39818 - 39826. [Abstract] [Full Text] [PDF]

				L. Marzban, G. Trigo-Gonzalez, and C. B. Verchere Processing of Pro-Islet Amyloid Polypeptide in the Constitutive and Regulated Secretory Pathways of {beta} Cells Mol. Endocrinol., August 1, 2005; 19(8): 2154 - 2163. [Abstract] [Full Text] [PDF]

				M. E. Bell, T. J. McDonald, and D. A. Myers Proopiomelanocortin Processing in the Anterior Pituitary of the Ovine Fetus after Lesion of the Hypothalamic Paraventricular Nucleus Endocrinology, June 1, 2005; 146(6): 2665 - 2673. [Abstract] [Full Text] [PDF]

				K. Ueda, G. M. Lipkind, A. Zhou, X. Zhu, A. Kuznetsov, L. Philipson, P. Gardner, C. Zhang, and D. F. Steiner Mutational analysis of predicted interactions between the catalytic and P domains of prohormone convertase 3 (PC3/PC1) PNAS, May 13, 2003; 100(10): 5622 - 5627. [Abstract] [Full Text] [PDF]

				E. A. Nillni, W. Xie, L. Mulcahy, V. C. Sanchez, and W. C. Wetsel Deficiencies in Pro-thyrotropin-releasing Hormone Processing and Abnormalities in Thermoregulation in Cpefat/fatMice J. Biol. Chem., December 6, 2002; 277(50): 48587 - 48595. [Abstract] [Full Text] [PDF]

				A.-M. Khatib, G. Siegfried, M. Chretien, P. Metrakos, and N. G. Seidah Proprotein Convertases in Tumor Progression and Malignancy : Novel Targets in Cancer Therapy Am. J. Pathol., June 1, 2002; 160(6): 1921 - 1935. [Abstract] [Full Text] [PDF]

				R. Kuliawat, D. Prabakaran, and P. Arvan Proinsulin Endoproteolysis Confers Enhanced Targeting of Processed Insulin to the Regulated Secretory Pathway Mol. Biol. Cell, June 1, 2000; 11(6): 1959 - 1972. [Abstract] [Full Text]

				N. G. SEIDAH, S. BENJANNET, J. HAMELIN, A. M. MAMARBACHI, A. BASAK, J. MARCINKIEWICZ, M. MBIKAY, M. CHRETIEN, and M. MARCINKIEWICZ The Subtilisin/Kexin Family of Precursor Convertases: Emphasis on PC1, PC2/7B2, POMC and the Novel Enzyme SKI-1 Ann. N.Y. Acad. Sci., October 20, 1999; 885(1): 57 - 74. [Abstract] [Full Text] [PDF]

				C. Rovere, J. Luis, J.-C. Lissitzky, A. Basak, J. Marvaldi, M. Chretien, and N. G. Seidah The RGD Motif and the C-terminal Segment of Proprotein Convertase 1 Are Critical for Its Cellular Trafficking but Not for Its Intracellular Binding to Integrin alpha 5beta 1 J. Biol. Chem., April 30, 1999; 274(18): 12461 - 12467. [Abstract] [Full Text] [PDF]

				E. Apletalina, J. Appel, N. S. Lamango, R. A. Houghten, and I. Lindberg Identification of Inhibitors of Prohormone Convertases 1 and 2 Using a Peptide Combinatorial Library J. Biol. Chem., October 9, 1998; 273(41): 26589 - 26595. [Abstract] [Full Text] [PDF]

				P. Barbero, C. Rovere, I. De Bie, N. Seidah, A. Beaudet, and P. Kitabgi PC5-A-mediated Processing of Pro-neurotensin in Early Compartments of the Regulated Secretory Pathway of PC5-transfected PC12 Cells J. Biol. Chem., September 25, 1998; 273(39): 25339 - 25346. [Abstract] [Full Text] [PDF]

				A. Zhou, S. Martin, G. Lipkind, J. LaMendola, and D. F. Steiner Regulatory Roles of the P Domain of the Subtilisin-like Prohormone Convertases J. Biol. Chem., May 1, 1998; 273(18): 11107 - 11114. [Abstract] [Full Text] [PDF]

				Y. Rouille, S. Kantengwa, J.-C. Irminger, and P. A. Halban Role of the Prohormone Convertase PC3 in the Processing of Proglucagon to Glucagon-like Peptide 1 J. Biol. Chem., December 26, 1997; 272(52): 32810 - 32816. [Abstract] [Full Text] [PDF]

				Y. Qian, L. A. Devi, N. Mzhavia, S. Munzer, N. G. Seidah, and L. D. Fricker The C-terminal Region of proSAAS Is a Potent Inhibitor of Prohormone Convertase 1 J. Biol. Chem., July 28, 2000; 275(31): 23596 - 23601. [Abstract] [Full Text] [PDF]

				I. Jutras, N. G. Seidah, and T. L. Reudelhuber A Predicted alpha -Helix Mediates Targeting of the Proprotein Convertase PC1 to the Regulated Secretory Pathway J. Biol. Chem., December 15, 2000; 275(51): 40337 - 40343. [Abstract] [Full Text] [PDF]

				Y. Berman, N. Mzhavia, A. Polonskaia, and L. A. Devi Impaired Prohormone Convertases in Cpefat/Cpefat Mice J. Biol. Chem., January 5, 2001; 276(2): 1466 - 1473. [Abstract] [Full Text] [PDF]